NLRP3 gene silencing ameliorated the development of DCM in type 2 diabetic rat, by reducing cardiac inflammation, cardiomyocyte pyroptosis and left ventricular fibrosis. This evidence concerns the gene NLRP3 and familial dilated cardiomyopathy.